Search results for "Immunologic Test"

showing 4 items of 14 documents

The role of the reporting framework MIATA within current efforts to advance immune monitoring

2014

Quality Controlmedicine.medical_specialtyLaboratory Proficiency TestingConsensusmedicine.medical_treatmentInternational CooperationT-LymphocytesImmunologyImmune monitoringPharmacologyImmunologic TestsImmune assaysMonitoring ImmunologicPredictive Value of TestsmedicineImmunology and AllergyHumansCooperative BehaviorIntensive care medicineImmune monitoringObserver Variationbusiness.industryGuideline adherenceMIATAImmunologic TestsReproducibility of ResultsImmunotherapyTreatment OutcomeReportingPredictive value of testsPractice Guidelines as TopicCooperative behaviorLaboratory Proficiency TestingGuideline AdherenceImmunotherapyCurrent (fluid)businessLaboratories
researchProduct

�ber den Nachweis des Erythropoetins in der Gewebekultur

1958

business.industryAnemiaImmunologic TestsGeneral Medicinemedicine.diseaseMolecular medicineHuman geneticsTissue cultureDrug DiscoveryImmunologyMolecular MedicineMedicinebusinessGenetics (clinical)Klinische Wochenschrift
researchProduct

Cost-effectiveness of screening for colorectal cancer in France using a guaiac test versus an immunochemical test

2010

Objectives: The aim of this study was to compare the cost and the effectiveness of two biennial fecal occult blood screening tests for colorectal cancer: a guaiac nonrehydrated test (G-FOBT) and an immunochemical test (I-FOBT) with the absence of screening.Methods: A Markov model was developed to compare these strategies in a general population of subjects aged 50 to 74 over a 20-year period.Results: Compared with the absence of screening, G-FOBT and I-FOBT were associated with a decrease in colorectal cancer mortality of 17.4 percent and 25.2 percent, respectively. With regard to cost-effectiveness, expressed as cost per life-year gained, I-FOBT was the most effective and most costly alter…

medicine.medical_specialtyColorectal cancerCost effectivenessCost-Benefit Analysishealth care facilities manpower and serviceseducationPopulationImmunologic TestsSensitivity and SpecificityInternal medicinemedicineHumansMass ScreeningeducationSensitivity analyseshealth care economics and organizationsMass screeningAgedGynecologyeducation.field_of_studybiologybusiness.industryHealth PolicyEurosMiddle Agedmedicine.diseasebiology.organism_classificationMarkov Chainsdigestive system diseasesTest (assessment)surgical procedures operativeFecal occult blood screeningOccult BloodIndicators and ReagentsFranceColorectal NeoplasmsGuaiacbusinessInternational Journal of Technology Assessment in Health Care
researchProduct

Diagnostic Accuracy of a New Antigen Test for SARS-CoV-2 Detection

2021

Background and aims: Quick and reliable diagnostic tools play an important role in controlling the spread of the SARS-Cov-2 pandemic. The aim of this study was to evaluate the diagnostic accuracy of a new cyto-salivary antigen test aimed at detecting the presence of antigens for SARS-CoV-2, as compared by the gold standard RT-PCR and a lateral flow test. Methods: A total of 433 healthy volunteers were enrolled in the study and the sensitivity and specificity of the new cyto-salivary antigen test were calculated, as compared to the RT-PCR nasopharyngeal swab and to the lateral flow test. Results: A total of 433 samples were collected and tested at the Mediterranean Fair in Palermo from Febru…

medicine.medical_specialtyrespiratory disease COVID-19Coronavirus disease 2019 (COVID-19)Health Toxicology and MutagenesisSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)cyto-salivary testRT-PCRDiagnostic accuracyImmunologic TestsGastroenterologyAsymptomaticSensitivity and SpecificityArticlelateral flow testLateral flow test03 medical and health sciences0302 clinical medicineAntigenInternal medicinemedicineHumansImmunologic Test030212 general & internal medicinePandemics030304 developmental biology0303 health sciencesbusiness.industrySARS-CoV-2Public Health Environmental and Occupational HealthRCOVID-19Gold standard (test)Antigen testSARS-CoV-2.MedicineELISAmedicine.symptombusinessHumanInternational Journal of Environmental Research and Public Health
researchProduct